🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Common side effects of corona virus disease 2019 (COVID-19) include disrupt...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-06
Trial ID
NCT05760079
Treatments Being Tested
The purpose of this study is to determine whether treatment of unexplained ...
Status
Terminated
Location
Lakeview Medical Research
Start Date
2012-03
Trial ID
NCT01506726
Helicobacter pylori infection is closely related to gastritis, peptic ulcer...
Status
Completed
Location
Sixth afflicated of Sun-yat sen university
Start Date
2023-02-01
Trial ID
NCT05719831
To compare the pharmacokinetic characteristics between HCP1201 tablet 750/1...
Status
Completed
Location
Samsung Medical Center
Start Date
2013-12
Trial ID
NCT02026817
Treatments Being Tested
This study evaluated the tolerance, safety and efficacy of Apatinib plus Do...
Status
Unknown
Location
Sir Run Run Shaw Hospital
Start Date
2015-10
Trial ID
NCT03071042
This study will test two different formulations. The results will be used t...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-04
Trial ID
NCT00861458
Treatments Being Tested
The purpose of this study is to evaluate the effect that telaprevir has on ...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01038167
Treatments Being Tested
Low back pain is a common cause of visit to emergency department. It is not...
Status
Completed
Location
Montefiore Medical Center
Start Date
2016-03
Trial ID
NCT02665286
Treatments Being Tested
Primary objective of this study is to confirm the efficacy of HOE490 O (gli...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-05
Trial ID
NCT00924573
Treatments Being Tested
RATIONALE: Apatinib is a tyrosin-inhibitor agent targeting at vascular end...
Status
Completed
Location
Fudan University cancer hospital
Start Date
2011-04
Trial ID
NCT01531777